Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Akom Pharmaceuticals, Inc.
483
•Akom Pharmaceuticals, Inc.•May 16, 2018

Akom Pharmaceuticals, Inc. – FDA 483, May 16, 2018

Record Details

This FDA Form 483 was issued to Akorn, Inc., a sterile drug manufacturer located at 1222 W. Grand Ave., Decatur, IL 62522. The inspection occurred from April 9-20, May 3, and May 7-11, 16, 2018. Jonathan D. Shoemaker, Vice President and General Manager, was the recipient of the report.

The inspection revealed several observations:

* **Observation 1:** The firm failed to establish and follow appropriate written procedures to prevent microbiological contamination of sterile drug products, including validation of aseptic and sterilization processes. Specific issues included poor aseptic processing techniques (reaching over open vials, improper intervention execution, non-aseptic stopper addition, touching gowns then stopper bags, and replacing fallen vials). * **Observation 6:** An NDA-Field Alert Report was not submitted within three working days for: * A downward pH trend in Indocyanine Green (NDA no. 11-525) lots (021656, 31206, 041136, 051216, 061486). * Customer complaint investigation (PR # 78593) documenting "some dark spots/mold." * Failure to notify FDA when Acetylcysteine Injection 20

Company
Akom Pharmaceuticals, Inc.
Inspection date
May 16, 2018
Office
Chicago District Office
People
  • Sandra A. Hughes
  • Michele L. Glendenning
  • Michele Perry-Williams (Investigator)
View Company Profile

ID · 59e43e0f-88d9-4b22-911b-0af134c2877d

Violation Codes10
21 CFR 211.113(b)21 CFR 211.160(b)21 CFR 211.84(d)(2)21 CFR 211.166(a)21 CFR 211.67(b)21 CFR 211.42(c)(10)(iv)21 CFR 314.81(b)(1)(ii)21 CFR 211.180(a)21 CFR 211.110(a)21 CFR 211.25(a)

Full citation text and observation details available on the Dashboard.

Other documents for Akom Pharmaceuticals, Inc.
  • 483 - 2022-04-08April 8, 2022
  • 483 - 2018-04-09April 9, 2018
  • 483 - 2017-04-26April 26, 2017
  • 483 - 2016-06-10June 10, 2016
  • EIR - 2010-09-17September 17, 2010

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Akom Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.